Sumitomo Pharma Co., Ltd.
Pharmaceutical & medical device company payment data from CMS Open Payments.
Total Payments
$11.1M
Doctors Paid
22
Transactions
330
2024 Total
$3.5M
Payment Breakdown by Category
Research$7.0M (62.5%)
Consulting$121,656 (1.1%)
Travel$120,117 (1.1%)
Food & Beverage$2,570 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $7.0M | 39 | 62.5% |
| Charitable Contribution | $3.9M | 7 | 34.8% |
| Consulting Fee | $121,656 | 48 | 1.1% |
| Travel and Lodging | $120,117 | 161 | 1.1% |
| Honoraria | $63,909 | 25 | 0.6% |
| Food and Beverage | $2,570 | 50 | 0.0% |
Payments by Type
Research
$7.0M
39 transactions
General
$4.2M
291 transactions
Research Studies & Clinical Trials
| Study Name | Total Paid | Doctors | Records |
|---|---|---|---|
| research collaboration in the CNS area | $2.0M | 0 | 2 |
| Study of the Safety and Pharmacokinetics of KSP-1007 Alone and Coadministered With Meropenem in Healthy Subjects | $1.9M | 0 | 25 |
| An investigator-initiated clinical trial of safety and efficacy of transplantation of human induced pluripotent stem cell-derived dopaminergic progenitors (CT1-DAP000) for Parkinsons disease (Phase I/II) | $1.1M | 0 | 2 |
| Research collaboration in the CNS area. | $1.0M | 0 | 1 |
| Molecular and cellular profiling of the glial cells in delirium and related neurological conditions | $648,544 | 0 | 2 |
| Sleep Quality, Cognitive Performance, and Computerized Cognitive Training Benefits: Comparison of Patients treated with Lurasidone vs. Patients with Major depression Receiving SSRI Treatment as usual | $261,598 | 0 | 1 |
| KSP-1007 is under development for the treatment of hospital acquired pneumonia, complicated urinary tract infections and complicated intra-abdominal infections | $24,150 | 0 | 6 |
Payments by Medical Specialty
| Specialty | Total Paid | Doctors | Avg/Doctor |
|---|---|---|---|
| Psychiatry | $92,396 | 5 | $18,479 |
| Hematology & Oncology | $48,095 | 2 | $24,047 |
| Child & Adolescent Psychiatry | $31,062 | 2 | $15,531 |
| Medical Oncology | $30,266 | 2 | $15,133 |
| Endocrinology, Diabetes & Metabolism | $14,830 | 1 | $14,830 |
| Anesthesiology | $5,665 | 1 | $5,665 |
| Neurology with Special Qualifications in Child Neurology | $2,800 | 1 | $2,800 |
| Infectious Disease | $2,750 | 1 | $2,750 |
| Neurology | $2,750 | 3 | $916.67 |
| Internal Medicine | $1,544 | 1 | $1,544 |
| Nephrology | $1,500 | 1 | $1,500 |
| Clinical Molecular Genetics | $1,100 | 1 | $1,100 |
| Psychosomatic Medicine | $112.76 | 1 | $112.76 |
Top Paid Doctors
| Doctor | Specialty | Location | Total | 2024 |
|---|---|---|---|---|
| John Kane | Psychiatry | Glen Oaks, NY | $59,908 | $0 |
| Dr. Naval Daver, Mbbs, MBBS | Hematology & Oncology | Houston, TX | $46,695 | $0 |
| Dr. Takuya Saito | Child & Adolescent Psychiatry | Suginami, TOKYO | $26,162 | $0 |
| Prof. Akira Sawa, M.d, M.D | Psychiatry | Baltimore, MD | $23,457 | $0 |
| Dr. Raajit Rampal, Md, MD | Medical Oncology | New York, NY | $22,067 | $0 |
| Rohit Kulkarni, Md, MD | Endocrinology, Diabetes & Metabolism | Perth Amboy, NJ | $14,830 | $0 |
| Naoto Ueno, M.d. Phd, M.D. PHD | Medical Oncology | Honolulu, HI | $8,199 | $0 |
| Christoph Correll, Md, MD | Psychiatry | Glen Oaks, NY | $8,023 | $0 |
| Dr. Michael Hutchens, M.d, M.D | Anesthesiology | Portland, OR | $5,665 | $0 |
| Robert Findling, Md, MD | Child & Adolescent Psychiatry | Cleveland, OH | $4,900 | $0 |
| Jonathan Mink, Md, Phd, MD, PHD | Neurology with Special Qualifications in Child Neurology | Rochester, NY | $2,800 | $0 |
| Dr. Michael Dunne, Md, MD | Infectious Disease | Old Saybrook, CT | $2,750 | $0 |
| Shuta Ishibe, Md, MD | Internal Medicine | New Haven, CT | $1,544 | $0 |
| Dr. David Goldfarb, M.d, M.D | Nephrology | New York, NY | $1,500 | $0 |
| Dr. Tanios Bekaii-Saab, M.d, M.D | Hematology & Oncology | Scottsdale, AZ | $1,400 | $0 |
| Dr. Albert La Spada, Md, MD | Clinical Molecular Genetics | Orange, CA | $1,100 | $0 |
| Dr. Michael Rafii, M.d., Ph.d, M.D., PH.D | Neurology | La Jolla, CA | $1,050 | $0 |
| Ricardo Jorge, Md, MD | Neurology | Houston, TX | $1,000 | $0 |
| Dr. Murray Stein, M.d., M.p.h, M.D., M.P.H | Psychiatry | San Diego, CA | $1,000 | $0 |
| Dr. Horacio Kaufmann, M.d, M.D | Neurology | New York, NY | $700.00 | $0 |
| Gen Shinozaki, Md, MD | Psychosomatic Medicine | Stanford, CA | $112.76 | $0 |
Ad
Top Products
- Latuda $94,521
Payment Categories
- Food & Beverage $2,570
- Consulting $121,656
- Travel & Lodging $120,117
- Research $7.0M
About Sumitomo Pharma Co., Ltd.
Sumitomo Pharma Co., Ltd. has made $11.1M in payments to 22 healthcare providers, recorded across 330 transactions in the CMS Open Payments database. In 2024, the company paid $3.5M. The top product by payment volume is Latuda ($94,521).
Payments were distributed across 13 medical specialties. The top specialty by payment amount is Psychiatry ($92,396 to 5 doctors).
Payment categories include: Food & Beverage ($2,570), Consulting ($121,656), Research ($7.0M), Travel & Lodging ($120,117).